BiotechMashup

A new urine test will allow doctors to diagnose chlamydia infection in men within the hour, improving the ability to successfully treat the infection on the spot and prevent re-transmission.

(Wellcome Trust) An inexpensive new test for the detection of hepatitis B virus has been given regulatory approval for use in the European Union. The test, developed with support from the Wellcome Trust, delivers accurate results while-you-wait, enabling doctors to take immediate action on health decisions.

(Wellcome Trust) The Wellcome Trust and Merck & Co. Inc. today announced the creation of the MSD Wellcome Trust Hilleman Laboratories, the first of its kind research and development joint venture with a not-for-profit mission to focus on developing affordable vaccines to prevent diseases that commonly affect low-income countries.

(Wellcome Trust) Researchers in South East Asia have identified two genetic variants associated with increased susceptibility to severe dengue. The study, funded by the Wellcome Trust and the Agency for Science, Technology, and Research, Singapore, offers clues to how the body responds to dengue infection.

(Wellcome Trust) The Wellcome Trust today announces an injection of £110 ($168) million to extend its Seeding Drug Discovery initiative for a further five years. The decision follows an extensive internal review of the program, whose successes include the completion of a Phase I clinical trial of a drug to treat multidrug-resistant bacterial infections.

(Wellcome Trust) The Laboratory for Virology and Experimental Chemotherapy and the "Centre for Drug Design and Discovery" at K.U.Leuven will receive a total of 2.8 million euro from the British Wellcome Trust.They will apply these funds to the search for possible new medication for the treatment of infections related to the "dengue fever virus."

(Wellcome Trust) Wellcome Trust scientists have shown for the first time that exactly how we see our environment depends on the size of the visual part of our brain.

Urologists are failing to pick up and treat chlamydia infection in young men, say researchers in the UK.

(Wellcome Trust Sanger Institute) Researchers have identified an elusive gene responsible for Gray Platelet Syndrome, an extremely rare blood disorder in which only about 50 known cases have been reported. As a result, it is hoped that future cases will be easier to diagnose with a DNA test.The findings were made following a collaborative study by professor Willem Ouwehand and Dr. Cornelis Albers, from the Wellcome Trust Sanger Institute, and Dr. Paquita Nurden, from the Rare Platelet Disorders laboratory, based in Bordeaux.